Month: March 2020

MOORESTOWN, N.J., March 17, 2020 (GLOBE NEWSWIRE) — Tabula Rasa HealthCare, Inc. (TRHC) (NASDAQ: TRHC), a healthcare technology company advancing the field of medication safety, enters into an agreement with BioIntelliSense to distribute its BioSticker™, the first FDA-cleared, single-use device enabling 30 days of continuous vital sign monitoring. The BioIntelliSense DaaS platform can be applied to a wide range of clinical use cases, including monitoring for the key symptoms associated with COVID-191.“As TRHC serves a variety of healthcare clients, including the majority of PACE organizations in the United States, they are an outstanding partner for introduction of remote patient monitoring into the PACE market and beyond,” said BioIntelliSense CEO James Mault, MD. “The BioIntelliSense BioSticker device and data services are ideal...

Nasdaq OMX Copenhagen A/S                                                                 Meddelelse nr.         2 /2020Nikolaj Plads 6                                                                                          Fondskode DK 00102835971067 København K                                                                                    LEI kode   529900NJCIEGWTL0U036                                                         Den 17. marts 2020Andersen & Martini har i 2019 realiseret et resultat på kr. 2,3 mio. før skat og forventer fremgang i 2020 itakt med den forventede fremgang for Opel, Kia og Peugeot samt virkningen af de strukturelletiltag, der er foretaget. Dermed forventes et resultat før skat på mellem kr. 3 og 5 mio. for 2020.Denne forventning er i skrivende stund meget usikker i relation til corona-krisen.Bestyrelsen...

Nasdaq OMX Copenhagen A/S                                                           Meddelelse nr.         2 /2018Nikolaj Plads 6                                                                                     Fondskode DK 00102835971067 København K                                                               LEI kode 529900NJCIEGWTL0U036                                           Den 15. marts 2018Andersen & Martini har i 2017 realiseret et resultat på kr. 63 mio. før skat.Bestyrelsen for Andersen & Martini har i dag behandlet regnskabet for 2017. Årsrapporten er vedhæftet, men kan også ses på www.am.dk .En væsentlig del af overskuddet stammer fra salget af ejendommen i Lyngby. Selve driften har været præget af tilbagegangen for Opel og Kia, som delvis er opvejet af bedre processer og indtjening.Efter skat er det realiserede...

LOS ANGELES, March 17, 2020 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR) a clinical-stage biotechnology company focused on the development of first-in-class biological therapeutics for the treatment of Duchenne muscular dystrophy (DMD) and other rare disorders, today announced the expansion of its strategic plan to further develop the company’s exosome platform technologies. In conjunction with these efforts, Stephen Gould, Ph.D. has been appointed as Executive Consultant to guide Capricor’s development of exosome-based vaccines and exosome-based therapeutics.  Dr. Gould, a Professor of Biological Chemistry at Johns Hopkins University, is an internationally recognized exosome expert who brings an unparalleled understanding of exosome engineering to Capricor’s exosome-based research and development programs.“One of the...

QUEBEC CITY, March 17, 2020 (GLOBE NEWSWIRE) — (TSXV: HEO) – H2O Innovation Inc. (“H2O Innovation” or the “Corporation”) is pleased to present an update on the current status of the Corporation’s activities surrounding COVID-19.First, a supply chain risk assessment was carried out for the various business lines of the Corporation, but more particularly for Piedmont because of the international nature of its business. As a first step, let’s recall that Piedmont designs, manufactures and distributes flexible couplings and filter housings made of fiberglass, each representing 50% of its revenues. These filter housings are manufactured by a partner in Tunisia, and no significant delays have been recorded in connection with the current pandemic. Piedmont experienced minor delays in the manufacturing of flexible couplings made in China...

QUÉBEC, 17 mars 2020 (GLOBE NEWSWIRE) — (TSXV : HEO) – H2O Innovation inc. (« H2O Innovation » ou la « Société ») a le plaisir de présenter une mise à jour sur la situation actuelle des activités de la Société entourant la COVID-19.Tout d’abord, une évaluation des risques a été réalisée en ce qui concerne les chaines d’approvisionnement des différentes lignes d’affaires de la Société, mais plus particulièrement de Piedmont en raison de la nature internationale de ses affaires. Dans un premier temps, rappelons que Piedmont conçoit, fabrique et distribue des raccords flexibles et des filtres à cartouches faits de fibre de verre, représentant chacun 50% de ses revenus. Ces filtres à cartouches sont fabriqués par un partenaire en Tunisie, et aucun retard significatif n’a été enregistré en lien avec la pandémie actuelle. Piedmont a connu...

TEMPLE CITY, Calif., March 17, 2020 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced the launch of a Next Generation Sequencing based test for the Coronavirus Disease (COVID-19). Fulgent’s NGS test will be one of the market’s first diagnostic tests for the COVID-19 virus developed based on NGS technology. Fulgent and MedScan will begin accepting specimens for testing this week from healthcare providers, clinics and reference labs.Built on advanced Next Generation Sequencing (NGS) technology, Fulgent’s COVID-19 test will be more comprehensive compared to Reverse Transcriptase-Polymerase Chain Reaction (“RT-PCR”) tests on the market. Fulgent’s test will sequence the entire viral...